Brain Cancer

Malignant tumors of the brain or spinal cord represent about 1 percent of all cancers. Michael Feuerstein, Ph.D., M.P.H., is among that small percentage.

Patients with glioblastoma multiforme (GBM) saw a 37 percent reduced risk of death and increased overall survival (OS) when treated with tumor treating fields (TTFields), according to a landmark analysis of the findings from the EF-14 trial.

As researchers test new treatments for GBM, understanding the unique needs of patients with this diagnosis and their caregivers remains crucial.

A recent study found that individuals who had the chickenpox virus when they were younger were less likely to eventually develop gliomas.

Former Vice President Joe Biden is launching a cancer nonprofit to tackle some of the hard-hitting issues patients with cancer face, such as high drug prices.

BethAnn Telford recently spent a week running a marathon a day on each of the seven continents to raise money and awareness for childhood cancers. This is after her own brain cancer diagnosis more than a decade ago.

Though now used for patients with grade 4 brain tumors, tumor treating fields are being tested for use in grade 3 tumors.

Genetics can help determine a patient's risk of developing a brain tumor, as well as what treatments may work.

The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.

Dellann Elliott Mydland, founder and president of the EndBrainCancer Initiative and 2016 GBM Hero, discusses how miracles do happen in the world of glioblastoma multiforme (GBM), and people survive.

Fran Drescher, actress, author and 16-year cancer survivor, spoke at CURE's GBM Heroes event.

The combination of onartuzumab and Avastin (bevacizumab) showed no additional benefit for patients with glioblastoma, according to a recent study.

​Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).

Author Anna Dewdney died of brain cancer, but instead of having funeral arrangements, she asked that people spend their time reading to children.

Sumul N. Raval, M.D., founder and director of the Zocchi Brain Tumor Center at Monmouth Medical Center and 2016 GBM hero, tells his patients, "I'm your quarterback."

Icotinib greatly improved intracranial progression-free survival for patients with lung cancer who have brain metastases, according to a recent study.

In the future, entrectinib may play an increasing role in the treatment of brain tumors, as well as other cancers.

We all deal with pain. For some of us, it is chronic, but we can't give up. Pain can be a tricky partner to walk along side and is different for everyone. For me, I must face it. I must try to heal it, and I must try to take steps forward, no matter how tiny they may be.

Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.

People from around the country, including actress and 16-year cancer survivor Fran Drescher , came to CURE's GBM Heroes event, honoring those who made an impact in the world of glioblastoma multiforme.

A promising treatment option is on the horizon for some patients with glioblastoma multiforme (GBM), says Martin van den Bent, M.D., Ph.D.

It can be hard to name our fears, especially when we are worried that others don't share them or that they will make us feel like a part of our community. In sharing, we can name stressors, activate healing from those stressors and give our bodies a chance to cope with all that has happened to us.

Tumor-treating fields are having a huge impact on the treatment and outcomes of patients with glioblastoma multiforme (GBM).

Rimas Lukas discusses the evolving field of glioblastoma multiforme (GBM) treatment.

A recent study showed that caregivers of patients with high-grade gliomas experience a great amount of time burden, even in the earlier stages of diagnosis.